Tag: HEB

Blue Horseshoe Stocks: DAL, GALT Updates & More


Delta Air Lines, Inc. DAL  – Options Recap

We followed a range of Delta options beginning on Thursday morning, when we signaled the DAL Weekly $57-58 Calls in the wake of the company’s across-the-board Q4 earnings beat. We were glad to report on Friday that in a single session those three sets of contracts yielded gains ranging from roughly 780% to 1980%

Despite making such big moves already, Friday’s session brought more success for our tracked calls, so we wanted to open up this short trading week with a final recap on the maximum gains allowed by those excellent weekly contracts. The total ranges we observed over just two sessions were amazing.

$57 Calls – Range: .24-3.44 – Max Gain: 1313%
$57.50 Calls – Range: .14-2.96 – Max Gain: 2014%
$58 Calls – Range: .06-2.40 – Max Gain: 3900%

Galectin Therapeutics, Inc. GALT

We also want to swing back around for GALT, a stock we routinely tracked throughout 2017. It finished off that yea with a bang, and has continued its excellent run into 2018.

From lows it saw at the beginning of December at 1.28, to the new highs it made at the end of last week at 6.15 , GALT had executed a 380% increase in roughly five weeks!

Extended Watchlist:
NCTY, HEB, BB, OSIS, OTIV, HAWK

Blue Horseshoe Stocks: Options Review & More

ProShares Short VIX Short-Term Futures ETF (SVXY) – Recap

We had some positive jobs numbers which posted on Friday, and to go along with the direction of the market activity we were observing, we highlighted a range of weekly options contracts in the SVXY ETF.

Our targets were the SVXY Weekly $152-154 Calls and we did see some pretty good movement from plays in that range, which made appreciable moves on the day. Those total possible gains were as follows:

$152 Calls – Range: 2.34-3.91 – Max Gain: 67%
$153 Calls – Range: 1.86-3.54 – Max Gain: 90%
$153.50 Calls – Range: 1.61-2.28 – Max Gain: 42%
$154 Calls – Range:1.15-2.71 – Max Gain: 136%

ShiftPixy, Inc. PIXY

The Friday before last, we signaled newly-IPO’d PIXY for observation on its first trading day ever, and it also performed admirably during last week’s short trading week.

After starting at a price of 6.30 on Friday (06/30), PIXY began to run, and this past Friday it hit a high of 10.50. That’s a solid 66% upswing, which is quite impressive for a first week of trading.

This morning, we’ve seen our observed range on PIXY increase even further to 78% with the stock managing a premarket high of 11.20.

We’ll be anxious to pick up where we left off and continue to track this new stock as we head into a new trading week. Each new high it sets is a new all-time high, so there’s no telling where this ride will let off. As we mentioned last week, we’ll just continue to monitor the stock, looking for higher base levels of support to be established as we go forward.

Inpixion INPX

We’re always looking for a good bottom play, and we have one with some potential in INPX, which tumbled last week after the company announced a hefty $6M public offering.

The offering was priced at 1.05/share and the stock is currently trading in the high-.60’s. We feel a return to at least the offering price would not be implausible.

Stocks coming off of recently-established 52-week lows have historically been good to us, so we want to place INPX on watch for a potential recovery.

Extended Watchlist:
AVEO, ATOS, HEB, KOOL, MSDI, PLX


Blue Horseshoe Stocks: GEO Options on a Roll & More


The GEO Group, Inc. – Options Review

GEO has earned itself top billing in our report for the second day running, as the stock continued its rebound yesterday, reaching new highs, and pushing our options ideas deeper into the money. Despite multi-bag gains on Friday, we reasserted our interest in continuing to follow them, and it was definitely the right move.

The GEO 09/16 $20 and 22.50 Calls were the targets we introduced on Friday morning, and our observed gains were extended by a healthy margin yesterday as GEO rose to a high of $25 even during the session.

The $20 Calls traded in a range from 4.00 up to 5.12, an intraday swing of 28% and an total two-day increase over our observed low of 1.61 amounting to 211%

The $22.50 Calls traded up from 2.25 to 3.05 running 36% intraday, and representing an overall increase of 251% from Friday’s low of .87.

As we stated yesterday, these ideas should remain good for as long as GEO sustains this strong rebound pattern.

Best Buy Co. Inc. BBY – Fresh Idea

BBY is flying high in the premarket this morning in the wake of its earnings release which contained a major increase in same-store sales for the quarter.

With the type of activity we’re witnessing early on this morning, we’re going to want to signal a range of options calls to observe here as well. Our specific contracts of interest are going to be the BBY Weekly 36.50-39 Calls, which will hold our interest provided that BBY maintains support in the low $36-range on any pullbacks.

First Acceptance Corp. FAC – Bottom-Watch

We’re going to take this opportunity to declare a bottom-watch for FAC, which is currently feeling out its lowest prices in a month after peeling back off of a massive run in late July.

On the chart below, we’ve highlighted the channel between recent swing lows at 1.01 and 1.15 as the area where we’d like to see a bottom-bounce occur, and we’ll have FAC on our radars in the days ahead for the possibility of that occurring.

Extended Watchlist:
DATA, WPFH, STML, TGD, HEB, BCCI(Potential Bottom)

Blue Horseshoe Stocks: CYBR, MCP, MEIP & More

CyberArk Software, Ltd. CYBR

Our first experiences with CYBR were good ones, when we successfully called a couple of potentially lucrative options trades around the middle of last month. It was in our report from February 13ththat we targeted CYBR $50 and $55 Calls, and that day we saw moves in those contracts of 72% and 165% respectively.
–
We flagged CYBR once again yesterday, which had previously been under several weeks of consolidation, yet was gapping up in the premarket. The stock did well in reversing its path, trading in a range from 50.79-55.03, and holding the majority of those gains into the close.

Our current options idea is going to be the 04/17 $50 Calls (Closed at 6.60 yesterday). Should CYBR reach its way back to the $60-level anytime in the next few weeks, the gains we see in those contracts will be quite substantial.

Molycorp, Inc. MCP

MCP appeared in yesterday’s extended watchlist and demonstrated a reversal of its own. We’re going to place MCP on more intensive watch as the week progresses, as it has the markings of a potential bottom play.

We’ve illustrated some of the key characteristics of the chart below, which appears to be gearing up for what could be a big swing. The stock ran well over a dollar at the beginning of last month, so the potential for rapid gains has certainly been demonstrated.

MEI Pharma, Inc. MEIP

We’ve also got an eye on MEIP after the stock was crushed down to a 52-week low yesterday, following the company’s announcement of the failure of its cancer drug in middle-stage testing.

A single-session depreciation on the order of 70% is the hallmark of one heck of a knee-jerk reaction, and the stock appears to be gapping up slightly this morning, so we’ll be on the lookout for a recovery in MEIP shares in coming days.

Extended Watchlist:
IMGN, ATOS ISR, HEB, GEVO, NEPT

Blue Horseshoe Stocks: APT, VTAE, NEWC & More

Alpha Pro Tech Ltd. APT 

Here’s a past gainer that began to catch our attention yesterday- We jumped on APT for the first time back on October 10th, while the stock was in the middle of a huge run. We observed the low of 5.72 on that day, and the stock took just two more sessions to reach a high of 10.73, marking a move of 87%

Following that big spike, APT had been beaten back over the past couple weeks, and this week, has begun to bounce off support above the 50DMA (3.58). We want to pay attention as the stock attempts a recovery.

Vitae Pharma, Inc. VTAE

We want to put VTAE on our radar as we close out the week, and keep an eye on it moving forward. The stock is gapping up big this morning; it had already been on the incline prior to yesterday’s news that really served to heat things up.

VTAE announced it had received positive results from a couple of its Phase-1 trials for an Alzheimer’s treatment they claim “Demonstrated Greater Than 80% Reduction of an Alzheimer’s Disease Biomarker” >> VIEW PR

The statement indicated that the results would lead to further trials over the next several months, so we’re going to enter VTAE into the log and reserve it a spot on our watchlists.

New Columbia Resources, Inc. NEWC

NEWC is a play we want to radar and add to our expansive marijuana-stock watchlist. We’re always keeping our eyes peeled for new cannabis stocks to watch, and we caught this one on a news scan today.

The company announced that its “Colombian subsidiary, Sannabis S.A.S., has legally produced  a trial run of cannabis based products on an Indian reservation.”

Infinera Corp. INFN

INFN appeared in yesterday’s report and made a decent move on strong volume, to the tune of nearly 10X the monthly average. The stock traded in a range from 12.17-13.96, a 15% intraday increase. We’ll be keeping watch over this play into next week as well.

Extended Watchlist:
OMEX, HEB, RUBI, IBIO

Get Our FREE Daily Reports!

SUBSCRIBE